Skip to main content

Table 2 Patient-level risk factors considered for targeted MDRO screening upon admission

From: Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions

 

ESBL

(n = 122)

CPE

(n = 119)

MDR-Acinetobacter

(n = 62)a

MDR-Pseudomonas

(n = 63)a

VRE

(n = 72)

MRSA

(n = 148)

(n = number of centers performing a targeted screening for each pathogen)

Risk factors used for targeted admission screening (%)

 Known MDRO patient:

111 (91%)

111 (93%)

59 (95%)

60 (95%)

67 (93%)

143 (97%)

 Direct transfer from abroad:

114 (93%)

107 (90%)

41 (66%)

37 (59%)

54 (75%)

144 (97%)

 Direct transfer from Switzerlandb:

33 (27%)

29 (24%)

13 (21%)

14 (22%)

14 (19%)

71 (48%)

 Transfer from a long term care facility:

11 (9%)

7 (6%)

3 (5%)

4 (6%)

5 (7%)

32 (22%)

 Hospitalization abroad in the recent pastc:

103 (84%)

98 (82%)

37 (59%)

32 (51%)

47 (65%)

109 (74%)

 Travel in a country with endemic MDRO:

28 (23%)

34 (29%)

16 (25%)

18 (29%)

19 (26%)

35 (24%)

 Other:

38 (31%)

41 (34%)

23 (37%)

21 (33%)

21 (29%)

84 (57%)

  1. Abbreviations: ESBL extended-spectrum beta-lactamase, CPE carbapenemase-producing enterobacteriaceae, MDR multi-drug resistant, VRE vancomycin resistant enterococcus, MRSA methicillin resistant Staphylococcus aureus
  2. aMissing values for: MDR Acinetobacter baumanii = 1, MDR Pseudomonas aeruginosa = 1
  3. bMainly Western Switzerland and Tessin were targeted when considering a direct transfer from Switzerland
  4. cVarying timeframes considered as recent past, mainly from 6 to 12 months
Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us